NCT06052553

Brief Summary

This research is being done to investigate the novel neck strengthening device, TopSpin360 and its effectiveness on measures of neck strength and cognitive function.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
60

participants targeted

Target at P50-P75 for not_applicable healthy

Timeline
Completed

Started Sep 2023

Longer than P75 for not_applicable healthy

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 9, 2023

Completed
9 days until next milestone

First Submitted

Initial submission to the registry

September 18, 2023

Completed
7 days until next milestone

First Posted

Study publicly available on registry

September 25, 2023

Completed
2.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2026

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 1, 2026

Completed
Last Updated

October 24, 2025

Status Verified

October 1, 2025

Enrollment Period

2.6 years

First QC Date

September 18, 2023

Last Update Submit

October 22, 2025

Conditions

Keywords

Ice Hockey

Outcome Measures

Primary Outcomes (13)

  • Change in peak force

    Measured by a neck isometric device, maximal load in kilograms that could be applied to head before deviation from neutral position.

    Baseline, post-season (approximately 6 months)

  • Change in normalized peak force

    Measured by a neck isometric device, peak force divided by participant weight in kilograms.

    Baseline, post-season (approximately 6 months)

  • Change in force steadiness

    Measured by a neck isometric device, average peak force.

    Baseline, post-season (approximately 6 months)

  • Change in rate of force development (RFD)

    Automatically collected by the TopSpin360 device, the multi-planar rate of force development (RFD) in pounds of force per second collected in both clockwise and counterclockwise.

    Baseline, post-season (approximately 6 months)

  • Change in visuo-motor reaction time

    Measured by a neck isometric device, reported in milliseconds (ms)

    Baseline, post-season (approximately 6 months)

  • Change in blood biomarker levels

    Blood will be at a biomarker level. We will investigate 5 different markers: NfL, SNCB, vWF, SNCA, and BDNF. Each biomarker will be measured in Nanograms per Milliliter (ng/ml).

    Baseline, post-season (approximately 6 months)

  • Change in salivary biomarkers

    Salivary biomarkers are relatively new and we will investigate to see if NfL, SNCB, vWF, SNCA, and BDNF. Each biomarker will be measured in Nanometer per milliliter (ng/ml).

    Baseline, post-season (approximately 6 months)

  • Change in N100 Amplitude

    Electroencephalograph (EEG) recording of brain electrical activity N100 potential amplitude. This measures is subsequently linearly transformed to a standardized score on a 0-100 scale, with larger peak amplitudes and shorter peak latencies resulting in higher scores.

    Baseline, post-season (approximately 6 months)

  • Change in N100 Latency

    Electroencephalograph (EEG) recording of brain electrical activity N100 potential latency. Increased latencies are indicative of slower responses. Obtained by EEG recording of N100 potential amplitude. This measures is subsequently linearly transformed to a standardized score on a 0-100 scale, with larger peak amplitudes and shorter peak latencies resulting in higher scores.

    Baseline, post-season (approximately 6 months)

  • Change in P300 Amplitude

    Electroencephalograph (EEG) recording of brain electrical activity P300 potential amplitude. This measures is subsequently linearly transformed to a standardized score on a 0-100 scale, with larger peak amplitudes and shorter peak latencies resulting in higher scores.

    Baseline, post-season (approximately 6 months)

  • Change in P300 Latency

    Electroencephalograph (EEG) recording of brain electrical activity P300 potential latency. Increased latencies are indicative of slower responses. This measures is subsequently linearly transformed to a standardized score on a 0-100 scale, with larger peak amplitudes and shorter peak latencies resulting in higher scores

    Baseline, post-season (approximately 6 months)

  • Change in N400 Amplitude

    Electroencephalograph (EEG) recording of brain electrical activity N400 potential amplitude. Increased amplitudes are indicative of larger signals. This measures is subsequently linearly transformed to a standardized score on a 0-100 scale, with larger peak amplitudes and shorter peak latencies resulting in higher scores.

    Baseline, post-season (approximately 6 months)

  • Change in N400 Latency

    Electroencephalograph (EEG) recording of brain electrical activity N400 potential latency. Increased latencies are indicative of slower responses. This measures is subsequently linearly transformed to a standardized score on a 0-100 scale, with larger peak amplitudes and shorter peak latencies resulting in higher scores.

    Baseline, post-season (approximately 6 months)

Secondary Outcomes (1)

  • Change in King-Devick Test (KDT) scores

    Baseline, post-season (approximately 6 months)

Study Arms (2)

Control Group

NO INTERVENTION

Subjects will receive no intervention for the duration of the hockey season.

TopSpin360 Intervention Group

EXPERIMENTAL

Subjects will use TopSpin360, twice- weekly and use for the duration of the hockey season.

Device: TopSpin360

Interventions

Helmet training device used to train head to stay stable during jarring impacts through dynamic and multi-planar neck strengthening.

TopSpin360 Intervention Group

Eligibility Criteria

Age18 Years - 21 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Fluent English Speaker.
  • Medically cleared to play ice hockey.

You may not qualify if:

  • Clinically documented hearing issues.
  • In-ear hearing aid or cochlear implant.
  • Implanted pacemaker or defibrillator.
  • Metal or plastic implants in skull. lack of verbal fluency in the English language.
  • History of seizures.
  • Allergy to rubbing alcohol or EEG gel.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Mayo Clinic in Rochester

Rochester, Minnesota, 55905, United States

RECRUITING

Study Officials

  • Mario Hevesi, MD

    Mayo Clinic

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
BASIC SCIENCE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

September 18, 2023

First Posted

September 25, 2023

Study Start

September 9, 2023

Primary Completion

April 1, 2026

Study Completion

April 1, 2026

Last Updated

October 24, 2025

Record last verified: 2025-10

Data Sharing

IPD Sharing
Will not share

Locations